Upload
caroline-gilbert
View
213
Download
0
Embed Size (px)
Citation preview
Protocol
Immunoblotting and sequential lysis protocols for the analysis of
tyrosine phosphorylation-dependent signaling
Caroline Gilberta,b, Emmanuelle Rollet-Labellea,b, Adriana C. Caonc,Paul H. Naccachea,b,*
aCentre de Recherche en Rhumatologie et Immunologie, CIHR group on the Molecular Mechanisms of Inflammation,
Centre de Recherche du CHUL, Laval University, Ste.-Foy, Quebec, CanadabDepartment of Medicine, Faculty of Medicine, Laval University, Ste.-Foy, Quebec, Canada
cDepartment of Molecular Biosciences, University of Adelaide, North Terrace, Adelaide, Australia
Received 30 August 2002; accepted 5 September 2002
Abstract
In stimulated neutrophils, the majority of tyrosine-phosphorylated proteins are concentrated in Triton X-100 or NP-40
insoluble fractions. Most immunobiochemical studies, whose objective is to study the functional relevance of tyrosine
phosphorylation are, however, performed using the supernatants of cells that are lysed in non-ionic detergent-containing buffers
(RIPA lysis buffers). This observation prompted us to develop an alternative lysis protocol. We established a procedure
involving the sequential lysis of neutrophils in buffers of increasing tonicities that not only preserve and solubilize tyrosine-
phosphorylated proteins but also retain their enzymatic activities. The sequential lysis of neutrophils in hypotonic, isotonic and
hypertonic buffers containing non-ionic detergents resulted in the solubilization of a significant fraction of tyrosine-
phosphorylated proteins. Furthermore, we observed in neutrophils in which CD32 was cross-linked that the tyrosine kinase
activity of Lyn was enhanced in the soluble fraction recovered from the hypertonic lysis but not in that derived from the first
hypotonic lysis. Furthermore, we detected tyrosine kinase activity and the presence of the tyrosine kinase Syk in association
with CD32 in the soluble hypertonic lysis fraction. This fraction also contained most of the tyrosine-phosphorylated proteins
including Cbl, Syk and CD32 itself. The results of this study provide a new experimental procedure for the investigation of
tyrosine phosphorylation pathways in activated human neutrophils which may also be applicable to other cell types.
D 2002 Elsevier Science B.V. All rights reserved.
Keywords: Cbl; CD32; Detergent insolubility; Fcg receptors; Kinase activity; Lyn; Monosodium urate monohydrate crystals; Neutrophil;
Phagocytosis; Signal transduction; Syk; Tyrosine phosphorylation
1. Background
Neutrophils play a crucial role in host defense
against injury and infection as well as in the inflam-
matory response (Smith, 1994) by virtue of their
ability to mount a series of effector responses. Neu-
trophils respond to a wide variety of agonists and one
0022-1759/02/$ - see front matter D 2002 Elsevier Science B.V. All rights reserved.
PII: S0022 -1759 (02 )00347 -2
Abbreviations: HLB, hypotonic lysis buffer; HyperLB, hyper-
tonic lysis buffer; ILB, isotonic lysis buffer; LB, lysis buffer; RIPA,
rapid immunoprecipitation assay; SB, sample buffer.
* Corresponding author. CHUL, Room T1-49, 2705 Boulevard
Laurier, Ste.-Foy, Quebec, Canada G1V 4G2. Tel.: +1-418-654-
2772; fax: +1-418-654-2765.
E-mail address: [email protected]
(P.H. Naccache).
www.elsevier.com/locate/jim
Journal of Immunological Methods 271 (2002) 185–201
of the earliest events observed upon stimulation of
neutrophils is an increase in the level of tyrosine
phosphorylation of a number of proteins (Rollet et
al., 1994).
The mechanisms linking neutrophil surface recep-
tors to tyrosine kinase signaling are, however, incom-
pletely understood. Immunoprecipitation coupled
with immunoblotting is one of the most commonly
used immunochemical techniques for studying tyro-
sine phosphorylation-dependent pathways. This tech-
nique can potentially determine several important
characteristics of molecules under examination such
as their presence and quantities, their relative molec-
ular weights, their rates of synthesis or degradation,
and the presence of certain post-translational mod-
ifications. It can also provide information about
interactions between proteins, nucleic acids and
other ligands. These protocols depend on lysing
the cells under mild conditions (usually RIPA buf-
fers) containing cocktails of protease and phospha-
tase inhibitors. These lysates are then centrifuged
and the supernatants are used for subsequent immu-
noprecipitations. It is commonly observed, however,
that the profile of tyrosine-phosphorylated proteins
of whole neutrophils is rapidly lost or artificially
increased upon lysing the cells in classical RIPA
buffers (Al-Shami et al., 1997b; Naccache et al.,
1997). An alternative assay involving lysis under
denaturing conditions was previously developed to
preserve the phosphorylation levels in neutrophil
lysates (Al-Shami et al., 1997b). Although this
protocol allows the identification of tyrosine-phos-
phorylated proteins (Al-Shami et al., 1997a; Barabe
et al., 1998; Khamzina and Borgeat, 1998; Rollet-
Labelle et al., 2000; Gilbert et al., 2001), it disrupts
protein–protein interactions and inactivates most
enzymatic activities.
Most studies analyze the soluble fractions fol-
lowing lysis in RIPA buffers while discarding the
insoluble fractions. However, the formation of
detergent-resistant membrane structures (DRM,
DIGs or lipids rafts) into which tyrosine-phosphory-
lated proteins and tyrosine kinases tend to concen-
trate after receptor stimulation has been well-
described in a range of cell types (Brown and
London, 1998; Simons, 2000) including neutrophils
(Zhou et al., 1995; Yan et al., 1996; Barabe et al.,
2002). The function of these detergent-insoluble
structures appears to be related to signal trans-
mission and/or membrane trafficking. Accordingly,
tyrosine kinase activities were found to be increased
and concentrated in these insoluble fractions upon
ligation of phagocytic receptors in adherent human
neutrophils (Zhou et al., 1995; Yan et al., 1996).
Accurate analysis of tyrosine phosphorylation
events in these structures depends on the prepara-
tion of stable cell lysates that can be used as
starting material for their analysis by immunopreci-
pitation.
In the present study, a method designed to reach
the above aims, based on sequential cell lysis under
conditions of increasing tonicity, is described. Firstly,
we show the distribution and preservation of tyrosine-
phosphorylated substrates in human neutrophil lysates
prepared under native conditions. The results obtained
illustrate the inadequacy of using standard cell lysates
prepared under native conditions as starting material
in subsequent immunoprecipitation or co-immunopre-
cipitation protocols. Secondly, we observe, using our
modified protocol, that the tyrosine kinase activity of
Lyn is specifically increased in the hypertonic lysis
fractions. This fraction is enriched in GM1 ganglio-
side and cytoskeletal components. Thirdly, we show
in the hypertonic lysis fractions an association
between the tyrosine kinase Syk and cross-linked
CD32. Finally, we also observe that Cbl, Syk and
CD32 were highly tyrosine-phosphorylated, specifi-
cally in the soluble fraction of the hypertonic lysis
step. The use of this alternative protocol emphasizes
the critical importance of the complete monitoring of
the tyrosine phosphorylation status as well as of the
solubility and, when applicable, the enzymatic activ-
ity of each target molecule, in response to each
agonist.
2. Type of research
(i) Signal transduction.
(ii) Analysis of tyrosine phosphorylation profiles and
identification of tyrosine-phosphorylated sub-
strates.
(iii) Distribution of tyrosine-phosphorylated proteins
between soluble and insoluble fractions.
(iv) Measurements of tyrosine kinase activities upon
stimulation in the soluble and insoluble fractions.
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201186
3. Time required
(i) Cell isolation (2 h)
(ii) Cell stimulation and lysis (15–45 min)
(iii) Lysate immunoprecipitation (3 h)
(iv) Kinase activity (10–60 min)
(v) Electrophoresis (5 h or O/N)
(vi) Transfer to Immobilon PVDF membranes (3 h or
O/N)
(vii) Immunoblot (3–4 h).
4. Materials
4.1. Preparation of cells
HBSS 1� solution (Wisent Canadian Laborato-
ries, St.-Bruno, Quebec, Canada) containing 1.6
mM CaCl2 + 10 mM HEPES
2% of dextran solution (Pharmacia Biotech,
Dorval, Quebec, Canada in HBSS 1� )
Ficoll Paque (Wisent Canadian Laboratories)
10% trypan blue solution (Sigma-Aldrich Canada,
Oakville, ON, Canada).
4.2. Preparation of buffers
2� Laemmli’s sample buffer (2� SB)
125 mM Tris–HCl, pH 6.8
8% SDS
10% h-mercaptoethanol
17.5% glycerol
5 mM Na3VO4 (stock solution is prepared
as previously described (Papavassiliou,
1994))
20 mM p-nitrophenylphosphate
20 Ag/ml leupeptin
20 Ag/ml aprotinin
0.0025% bromophenol blue
2� lysis buffer (2�LB)
125 mM Tris–HCl, pH 6.8
4% SDS
3% h-mercaptoethanol
17.5% glycerol
5 mM Na3VO4
20 Ag/ml leupeptin
20 Ag/ml aprotinin
0.0025% bromophenol blue
Hypotonic lysis buffer (HLB)
0.1% NP-40 (10% NP-40, Calbiochem, La Jolla,
CA, USA)
20 mM Tris–HCl, pH 7.5 at 4 jC10 mM NaCl
1 mM EDTA
2 mM Na3VO4
10 Ag/ml aprotinin
10 Ag/ml leupeptin
2 mM PMSF (optional, to be added immedi-
ately prior to lysing the cells)
50 Ag/ml soybean trypsin inhibitor
3 mM DFP (to be added just prior to lysing the
cells. Take care to discard the tips in a tube
containing 1N NaOH in order to neutralize the
DFP)
Isotonic lysis buffer (ILB)
1% NP-40 (100% NP-40, Calbiochem)
20 mM Tris–HCl, pH 7.5 at 4 jC137 mM NaCl
1 mM EDTA
2 mM Na3VO4
10 Ag/ml aprotinin
10 Ag/ml leupeptin
2 mM PMSF
50 Ag/ml soybean trypsin inhibitor
Hypertonic lysis buffer (HyperLB)
1% NP-40 (from 100% NP-40, Calbiochem)
20 mM Tris–HCl, pH 7.5 at 4 jC400 mM NaCl
1 mM EDTA
2 mM Na3VO4
10 Ag/ml aprotinin
10 Ag/ml leupeptin
2 mM PMSF
50 Ag/ml soybean trypsin inhibitor
Immunoprecipitation wash buffer (IPPWashB)
1% NP-40 (from 100% NP-40, Calbiochem)
20 mM Tris–HCl, pH 7.5 at 4 jC137 mM NaCl
1 mM EDTA (omit in the last wash if measuring
kinase activity)
Kinase buffer (1�KB)
50 mM HEPES, pH 7.5
10 mM MgCl23 mM MnCl250 AM ATP (prepared from powder just prior to
starting the kinase assay)
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201 187
0.5 Ag of SAM68–GST per immunoprecipita-
tion.
4.3. Preparation of polyacrylamide gel (7.5–20%
SDS-PAGE)
30% acrylamide solution
0.3% bisacrylamide solution
This provides optimal separation for a wide range
of molecular weight proteins (8–150 kDa).
4.4. Preparation of transfer and blotting solutions
Transfer buffer
25 mM of Tris base
192 mM glycine
20% (v/v) methanol
Ponceau 1%
1.0 g Ponceau S
1.0 ml glacial acetic acid
99.0 ml H2O
Tris buffer/Tween 20 (TBS)
25 mM Tris HCl, pH 8.0
190 mM NaCl
0.15% (v/v) Tween 20
Blocking solution
2% (v/v) gelatin
100 ml TBS
Microwave for 30 s to dissolve gelatin or warm
in a water bath or on a hot plate. Cool to 37 jCbefore use.
4.5. Antibodies
(1) The polyclonal antibodies, anti-Cbl (sc-170,
1:1000), anti-Lyn (sc-15, 1:2000) and anti-
SAM68 (sc-333, 1:1000) are purchased from
Santa Cruz Biotechnology (Santa Cruz, CA,
USA). The rabbit anti-mouse heavy/light chains
(315-005-048) is purchased from Jackson Im-
mune Research (Mississauga, ON, Canada).
(2) The monoclonal antibodies anti-Syk (MAB88906,
1:1000), anti-phosphotyrosine (UBI 05-321, clone
4G10, 1:4000) are purchased from Chemicon
International (Missisauga, ON, Canada) and
Upstate Biotechnology (Lake Placid, NY, USA),
respectively. The monoclonal antibodies anti-
Ezrin (E53020, 1:5000), anti-p62 nucleoporin
(N43620, 1:1000) and the organelle Sampler kit
antibodies (611436) are obtained from Trans-
duction Laboratories (Lexington, KY, USA).
(3) An anti-FcgRII polyclonal antiserum against the
cytoplasmic tail of CD32 (CT-10) is generated in
our laboratory as described previously (Ibarrola et
al., 1997).
(4) Monoclonal anti-FcgRII antibodies (IV.3) are
purified from the ascites fluid of mice inoculated
with hybridoma HB 217, which is obtained from
the American Type Culture Collection (Rock-
ville, MD, USA). F(abV)2 fragments of the IV.3
antibody are prepared essentially as described in
the Pierce catalog (Rockford, IL, USA). Briefly,
the antibodies are digested with pepsin and
intact antibodies are eliminated by adding
protein A and protein G beads. The integrity
and purity of the F(abV)2 fragments are verified
by their ability to label intact human neutrophils
as determined by flow cytometry as well as by
their neutrophil-activating properties (calcium
mobilization, superoxide generation, tyrosine
phosphorylation).
4.6. Reagents
Soybean trypsin inhibitor, cholera toxin B-HRP
and sodium orthovanadate (Na3VO4) are purchased
from Sigma-Aldrich Canada. Di-isopropylfluorophos-
phate (DFP) (NP-40 10% and 100% solution) are
obtained from Calbiochem. p-Nitrophenylphosphate,
aprotinin and leupeptin are purchased from ICN
Pharmaceuticals (Costa Mesa, CA, USA). Sephadex
G-10, protein A sepharose are purchased from Phar-
macia Biotech. SAM68–GST fusion protein is ob-
tained from Santa Cruz Biotechnology.
4.7. Special equipment
1. Centrifuge
2. Microcentrifuge
3. Thermomixer R at 37 and 30 jC (Eppendorf)
4. Dry bath at 100 jC5. Sonicator
6. Rotator platform at 4 jC7. Peristaltic pump
8. Electrophoresis slab gel apparatus
9. Electrophoretic Transfer Unit
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201188
10. Power supply
11. Rocking platform
12. Microcentrifuge tubes.
5. Detailed procedures
5.1. Cell preparation
Peripheral blood is obtained from healthy adult
volunteers and collected on isocitrate anticoagulant.
Neutrophil suspensions are prepared sterilely as pre-
viously described (Pouliot et al., 1998), except that
sedimentation of erythrocytes is performed using 2%
dextran solution diluted in HBSS. The cells are
resuspended at a concentration of 107 cells/ml in
HBSS, pH 7.4, containing 1.6 mM calcium but no
magnesium in order to minimize aggregation. Cell
preparations with non spherical morphologies (an
indication of pre-activation) are excluded from the
study.
5.2. Cell stimulation
Before all stimulations, neutrophil suspensions
(4� 107 cells/ml) are pre-incubated at room temper-
ature with 1 mM DFP for 5 min. Neutrophils suspen-
sions of the same concentration are then stimulated
with the desired agonists at 37 jC. To cross-link
CD32, the cell suspensions are incubated with 2.0
Ag/ml of anti-FcgRII (IV.3) antibodies for 1 min at 37
jC and then with 20 Ag/ml of F(abV)2 goat anti-mouse
Fc antibody (Jackson Immune Research) for 1 min at
37 jC or the indicated periods of time. For immuno-
precipitations, the F(abV)2 fragment of IV.3 is used
instead of the whole antibody.
5.3. Preparation of total cell lysates under denaturing
conditions
After stimulation, the reactions are stopped by
transferring 100 Al of the cell suspensions directly to
an equal volume of boiling 2� sample buffer. The
samples are boiled for 7 min and vortexed frequently
to ensure that the cells have dissolved properly. The
samples are loaded immediately on SDS polyacryla-
mide gels, or stored at � 80 jC (if frozen, it is best to
reheat samples before loading onto gels.). It is critical
to add the cells directly to boiling sample buffer as
this greatly reduces the background levels of tyrosine
phosphorylation due to nonspecific activation. The
addition of DFP (1–4 mM) to the resuspension buffer
helps minimize proteolysis and activation caused by
centrifugation (Gilbert et al., 2001). The conditions
outlined above should apply equally to other leuko-
cyte populations.
5.4. Hypotonic cell lysis
After stimulation, the reactions are rapidly stop-
ped by transferring the cell suspensions to precooled
(� 20 jC) 1.5 ml microcentrifuge tubes. The cells
are then centrifuged for 5–10 s at 6000� g in a
microcentrifuge and the pellets resuspended at a
final concentration of 4� 107 cells/ml in the hypo-
tonic lysis buffer (HLB). For better inhibition of
phosphatases, 10 mM p-nitrophenylphosphate may
be added to the lysis buffer. After a 5-min incuba-
tion at 4 jC, the lysates are centrifuged at 600� g
for 10 min at 4 jC. Supernatants generated can be
used either for immunoprecipitation under native or
denaturing conditions, or for the determination of
tyrosine kinase activities, or transferred to an equal
volume of boiling 2� SB. Similarly, the resulting
pellets are either resuspended in HLB and then
transferred to an equal volume of boiling 2� SB,
or ILB or HyperLB for immunoprecipitation or
determination of tyrosine kinase activity. Nuclear
integrity and total cell lysis are routinely verified
by light microscopy.
5.5. Isotonic cell lysis
After stimulation, the reactions are rapidly stopped
by transferring the cell suspensions into precooled
(� 20 jC) 1.5 ml microcentrifuge tubes. The cell
suspensions are then centrifuged for 5–10 s at
6000� g in a microcentrifuge. The supernatants are
removed and the cell pellets are resuspended and
incubated for 5 min at 4� 107 cells/ml at 4 jC in
cold isotonic lysis buffer (ILB). The lysates are
centrifuged at 600� g for 10 min at 4 jC. Aliquotsof the supernatants are added to an equal volume of
boiling 2� SB. The pellets are resuspended in ILB
and then transferred to an equal volume of boiling
2� SB.
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201 189
5.6. Sequential solubilization
The soluble and insoluble fractions of the hypo-
tonic lysis are individually processed for subsequent
analysis. The soluble fraction is centrifuged at
180,000� g at 4 jC for 45 min. The supernatant is
analyzed by transfer of an aliquot into 2� SB. The
pellet is dissolved in 1 volume of HLB and transferred
to boiling 2� SB. The fraction insoluble in HLB is
resuspended in ILB and centrifuged for 10 min at
13,000� g. The soluble material of this second lysis
is transferred into 2� SB and the pellet is resuspended
in the hypertonic lysis buffer (HyperLB). Two 5-s
sonication steps may be necessary for maximal pellet
extraction depending on the individual sonicator used.
Some adjustment may be necessary to maximize
extraction and preservation of intact phosphorylated
products. The lysates are centrifuged at 13,000� g for
10 min at 4 jC. Aliquots of the supernatants of each
fraction (soluble HLB to soluble HyperLB) are trans-
ferred to an equal volume of boiling 2� SB. The
pellets are resuspended in HLB and then diluted in the
same volume of 2� SB. The samples are then electro-
phoresed as described above. The soluble fractions of
HyperLB are also used under native conditions for
immunoprecipitation and tyrosine kinase activity.
These fractions (soluble HyperLB) can also be
obtained by direct addition of HyperLB to the HLB
pellets. The experimental scheme illustrated in Fig. 1
shows the details of this procedure.
5.7. Immunoprecipitation under denaturing condi-
tions
Neutrophils are incubated and stimulated as
described above. Aliquots (500 Al) of the cells are
lysed by direct transfer to an equal volume of boiling
2� lysis buffer (2�LB) and boiled for 7 min.
Immunoprecipitations are performed as previously
described (Al-Shami et al., 1997b). Briefly, lysates
are filtered through sephadex G-10 columns to
remove the denaturing agents. The filtered lysates
are precleared with protein A-sepharose at 4 jC for
30 min in the presence of 1% NP-40, 2 mM orthova-
nadate, 10 Ag/ml leupeptin and 10 Ag/ml aprotinin.
The samples are then immunoprecipitated using 2 Agof anti-Cbl, 2 Ag of anti-Syk or 6 Ag of anti-CD32
previously bound to protein A-sepharose for 90 min at
4 jC on a rotator platform with constant end-over-end
mixing. The beads are collected and washed four
times with a lysis buffer containing 137 mM NaCl,
1% NP-40 but no SDS, h-mercaptoethanol or bromo-
phenol blue. Sample buffer (40 Al, 2� ) is added to
the beads which are then boiled for 7 min. The
proteins in the samples are then separated by electro-
phoresis as described above. The membranes are
blotted with anti-phosphotyrosine or with the immu-
noprecipitating antibodies (anti-Syk, anti-Cbl or anti-
CD32) for visualizing the amounts of precipitated
protein.
5.8. Native immunoprecipitation and tyrosine kinase
activity
The aliquots of HLB or HyperLB supernatant
lysates are mixed with HyperLB or HLB, respectively,
to bring back the NaCl and NP-40 concentrations to
137 mM and 1%, respectively. These isotonic lysates
are immunoprecipitated using 1.5 Ag of anti-Lyn or 3
Ag of rabbit anti-mouse heavy/light chain antibodies
(for CD32 immunoprecipitation) for 90 min at 4 jCon a rotator platform with constant end-over-end
mixing. The RAM antibodies recognize the anti-
CD32 fragment antibodies fixed on the cells during
stimulation and do not react with the goat anti-mouse
antibodies used for cross-linking CD32. Fifty micro-
liters (30% slurry) of protein A-sepharose is then
added and the samples are incubated for 1 h at 4
jC. The beads are collected and washed four times
with ILB buffer without EDTA. The beads are incu-
bated at 4 jC in kinase buffer and transferred to 37 jCfor the indicated times. The reactions are stopped by a
quick spin and the supernatants are discarded and then
2� SB is added to the beads. In the case of SAM68–
GST, when present in the KB mix, the supernatants
are precipitated with sepharose–GST beads and
washed twice with ILB buffer. Sample buffer (40 Al,2� ) is added to the beads which are then boiled for 7
min. The proteins in the samples are then separated by
electrophoresis as described above. The membranes
are blotted with the anti-phosphotyrosine or with the
specific immunoprecipitation antibodies for visualiz-
ing the amounts of precipitated protein. Immunopre-
cipitation with control rabbit IgG followed by kinase
activity is undertaken in parallel to verify the specif-
icity of the precipitations.
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201190
5.9. Detailed electrophoresis and immunoblotting
procedure
Prior to loading onto 7.5–20% SDS-PAGE acyla-
mide gels, samples in 2� SB are boiled for 7 min.
Proteins are then transferred to Immobilon PVDF
membranes (Millipore, Bedford, MA, USA). Gradient
gels (7.5–20%) and Immobilon PVDF membranes
have been found to be optimal for monitoring the
overall profile of tyrosine phosphorylation and for
effectively binding the majority of transferred pro-
teins. After transfer, the proteins are visualized with a
1% (w/v) Ponceau solution and the molecular weights
markers are identified. Nonspecific sites are blocked
with a 2% (w/v) gelatin solution for 30–60 min on a
rocking platform (not an orbital shaker). Dried milk
(i.e., Blotto) is not recommended as a blocking
solution for tyrosine phosphorylation immunoblotting
as it increases background. All subsequent incuba-
tions are performed on a rocking platform with con-
stant but not too vigorous rocking. We have found it
important to have only one membrane per container.
The blocking solution is discarded and replaced with a
2% gelatin solution containing a 1:4000 dilution of
anti-phosphotyrosine antibody (UBI 05 321) and
incubated for 1 h at 37 jC. The containers are rinsed
with water to remove any residual antibody solution
and the membranes are then washed with TBS 1�(three washes of 2 min each). The membranes are then
incubated with conjugated secondary antibody, either
goat anti-mouse-HRP antibodies ((#NXL-931)
1:20,000, Amersham/Pharmacia, Baie D’Urfe, QC,
Canada) or donkey anti-mouse-HRP antibodies
([#715-035-150] Jackson Immune Research) in 2%
gelatin solution or in TBS/Tween for 30–60 min at 37
jC or at room temperature equivalently. The secon-
dary antibody solution can only be used once and
should be made fresh for each assay. The containers
are rinsed with water and the membranes washed four
times for 5 min in a container with a large volume of
TBS/Tween (e.g., for a 12� 12 cm membrane, around
125 ml of TBS/Tween per wash). Care needs to be
taken when handling the membranes as any damage
can increase background staining. The detection sys-
tem solution is prepared as described in the data sheets
of the manufacturer (NEN Life Science, Boston, MA).
The membranes are placed protein facedown in a
clean container with the detection solution for 1 min
at room temperature without agitation. The solution is
dripped away for a few seconds and the membranes
are placed on a sheet of plastic food wrap large
enough to cover the membrane completely. The edges
are sealed and the membranes placed protein side up
in an autoradiography cassette. For clear and well-
focussed bands, the exposure of the film to the
membranes in the cassette should be conducted with-
out intensifying screens. For the other antibodies,
immunoblotting is performed using the appropriate
antibodies (anti-Cbl (1:1000), anti-CD32 (1:1000),
anti-SAM68 (1:1000) and anti-Syk (1:1000)) and
revealed using the Renaissance detection system
(NEN Life Science) using HRP-conjugated secondary
donkey anti-mouse [#715-035-150] or donkey anti-
rabbit [#711-035-152] antibodies (Jackson Immune
Research) at a dilution of 1:20,000 as described
above.
6. Results
6.1. Experimental schema of the sequential solubili-
zation protocol
Tyrosine phosphorylation in total neutrophil
lysates can be analyzed by immunoprecipitation
under denaturing conditions as illustrated in the left
side of Fig. 1. A major limitation of this technique
(Al-Shami et al., 1997b) is that it is impossible to
simultaneously monitor tyrosine kinase activity.
Aware of this limitation, we developed an alternate
protocol which preserved the tyrosine phosphoryla-
tion and the kinase activity and which is based on an
initial lysis in a hypotonic buffer (Gilbert et al.,
2002). The soluble and insoluble fractions of the
hypotonic lysis are therefore individually processed
for subsequent analysis as indicated in the right side
of Fig. 1.
We wanted to better characterize the soluble
fraction of the hypotonic lysis. After stimulation,
the soluble fraction of the hypotonic lysis is centri-
fuged for 45 min at 180,000� g. The resulting
soluble and insoluble fractions can be analyzed by
immunoblotting with anti-phosphotyrosine or other
antibodies.
Since most of the tyrosine-phosphorylated pro-
teins are recovered in the pellets following hypo-
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201 191
tonic lysis, a further extraction of this pellet is
warranted in order to carry out immunoprecipita-
tions from this fraction. The HLB-insoluble fraction
is sequentially lysed in buffers of increasing tonic-
ity, the composition of which is described in
Section 4 (detailed procedures). Briefly, the HLB-
insoluble material is resuspended in ILB (dotted
line) or in HyperLB, and separated after centrifu-
gation into the soluble and insoluble fractions. The
ILB-insoluble material is then resuspended in
HyperLB, and soluble and insoluble fractions are
isolated after centrifugation. The relevant fractions
are analyzed by immunoblotting with anti-phospho-
tyrosine antibodies (Fig. 2, panel A), or immuno-
precipitated for the analysis of the translocation,
phosphorylation or kinase activity of various pro-
teins as illustrated in Fig. 3.
6.2. Effect of tonicity of the lysis buffer on the
preservation and distribution of tyrosine phosphory-
lation patterns and signaling-associated molecules
The difficulties associated with the preservation of
phosphotyrosine profiles and protein integrity in
human neutrophils have previously been described
(Al-Shami et al., 1997b; Naccache et al., 1997). The
extraction of tyrosine-phosphorylated proteins is
known to be affected by the composition of the lysis
buffer (Ignatoski and Verderame, 1996); the pH,
presence of phosphate, salt concentration, cell con-
centration, presence of cations, protease and phos-
phatase inhibitors can all modify the detergent
behavior and the solubilization of individual pro-
teins. Previous studies have reported the solubiliza-
tion of proteins without affecting the structure of the
Fig. 1. Experimental schema of sequential solubilization protocol. This schema represents several alternatives for studying the tyrosine kinase
pathway in the neutrophil. This procedure is also applicable for the other cells.
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201192
nuclei using a hypotonic lysis buffer coupled with
low concentrations of detergents (0.1% NP-40) (Pou-
liot et al., 1996; McDonald et al., 1998; Gilbert et
al., 2001, 2002). The data in Fig. 2 compare this
hypotonic buffer (HLB) with a more classical iso-
tonic RIPA buffer (ILB). The soluble and insoluble
fractions of the two lysis buffers (lanes 3–10) are
compared to the whole cell lysates (lanes 1–2). The
protein (Coomassie blue staining) and tyrosine phos-
phorylation profiles are illustrated in panels A and B
for the soluble (lanes 3–4, 7–8) and insoluble (lanes
5–6, 9–10) fractions derived from these cell lysis
protocols. To study the tyrosine phosphorylation
profile, neutrophils are stimulated by cross-linking
CD32 for 1 min at 37 jC as described in Section 4
(detailed procedure). The samples are analyzed by
Fig. 2. Distribution and preservation of tyrosine phosphorylation profiles in HLB and ILB. Neutrophils (4� 107 cells/ml) are stimulated by
cross-linking CD32 as indicated in the detailed procedure. The reactions are stopped by a transfer of cell aliquots into a precooled Eppendorf
tube followed by rapid centrifugation. The appropriate lysis buffer is then added to the cell pellet, HLB for lanes 3–6 and ILB for lanes 7–10 or
in the boiling 2� SB for lanes 1 and 2. Aliquots of soluble (lanes 3,4 and 7,8) and insoluble (lanes 5,6 and 9,10) fractions are diluted in an equal
volume of 2� SB. The samples are analysed by Coomassie blue protein staining (panel A) or by Western blot with anti-phosphotyrosine
(panel B).
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201 193
Coomassie blue protein staining (panel A) or by
immunoblotting with anti-phosphotyrosine antibodies
(panel B), respectively.
The percentage of lysed cells and the integrity of
the nuclei are routinely verified by light microscopy
(data not shown) or by immunoblot analysis with
Fig. 3. Tyrosine kinase activity in the hypotonic and hypertonic soluble fractions. Neutrophils (4� 107 cells/ml) are stimulated by cross-linking
CD32 for 1 min at 37 jC as described in detailed procedure. The reactions are stopped by a transfer in a precooled Eppendorf tube followed by
rapid centrifugation. The HLB+ p-nitrophenylphosphate is added to the cell pellet. The aliquots (200 Al or 8� 106 equivalent cells) of the HLB
lysate supernatants are diluted with 200 Al of HyperLB and 200 Al of HLB. The pellet of the hypotonic lysis is directly incubated in a second
lysis buffer (HyperLB) and sonicated 2� 5 s. The soluble material (200 Al or 8� 106 equivalent cells) of this lysate are diluted in 2 volumes of
HLB and incubated with the anti-Lyn antibodies, and the kinase activity is performed as described in the detailed procedure. Aliquots of each
fraction are analysed by immunoblotting with an anti-phosphotyrosine antibodies in a panel A. Autophosphorylation is visualised by Western
blot with anti-phosphotyrosine antibody in a panel B.
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201194
nuclear markers such as p62 nucleoporin (a constitu-
ent of nuclear membranes) (Fig. 4). This confirmed
that the cells are completely lysed in the two buffers
and that nuclear integrity is better preserved in HLB
than in ILB (data not shown). Coomassie blue staining
(panel A) of these samples indicated that the amount
of protein extracted with the two lysis buffers is
roughly similar.
The tyrosine phosphorylation profile induced by
CD32 cross-linking, as monitored after the direct
transfer of the cells into sample buffer is illustrated
in the first two lanes of panel B and served as a
reference point for the evaluation of the adequacy of
the native cell lysates. Two major conclusions can be
drawn from monitoring the tyrosine phosphorylation
profiles in the various fractions (panel B). Firstly,
tyrosine-phosphorylated proteins are concentrated in
the insoluble fractions in both lysis protocols (lanes
5–6 and 9–10). Secondly, the tyrosine phosphoryla-
tion profiles are significantly better preserved in HLB
than in ILB (lanes 4–6 versus lanes 8–10).
Based on the three criteria, (i) prevention of pro-
teolysis (Gilbert et al., 2002), (ii) preservation of
tyrosine phosphorylation and (iii) day-to-day reprodu-
cibility of tyrosine phosphorylation levels (data not
shown), the data in Fig. 2 indicate that HLB is a
superior buffer for the preparation of starting material
from which to study tyrosine phosphorylation-
dependent signaling events in human neutrophils than
is ILB.
6.3. Sequential solubilization of the tyrosine-phos-
phorylated proteins
Since most of the tyrosine-phosphorylated pro-
teins are recovered in the pellets of the hypotonic
lysis, a further extraction of this pellet is warranted
in order to be able to carry out immunoprecipitation
from this fraction. On the other hand, it is important
to better characterize the soluble fraction of the
hypotonic lysis. The soluble and insoluble fractions
of the hypotonic lysis buffer are therefore individu-
ally processed for subsequent analysis. Fig. 3 shows
the anti-phosphotyrosine analysis of the soluble and
the insoluble fractions of the HLB (panel A) coupled
with the evaluation of the kinase activity of Lyn
(panel B).
After stimulation with the IV.3 F(abV)2, the solublefractions (lanes 3–4) of the hypotonic lysis are
conserved for immunoprecipitation with anti-Lyn
antibodies. The HLB-insoluble fraction is directly
lysed in HyperLB buffers and the soluble fractions
of this second lysis are conserved. The relevant
fractions are analyzed by immunoblotting with anti-
phosphotyrosine antibodies (panel A). The whole cell
lysates (lanes 1–2) served as the reference point for
the extent of stimulation as far as the global tyrosine
phosphorylation profile is concerned. As shown in
Fig. 3, the majority of the tyrosine-phosphorylated
proteins present in the pellet of the HLB are solubi-
lized and preserved in HyperLB (lanes 7–8) although
some tyrosine-phosphorylated proteins (lanes 9–10)
remained insoluble.
6.4. Lyn activity following its extraction from
HyperLB
In order to assess the state of the proteins
extracted in HyperLB, the immunoreactivity and
enzymatic activity of the Src kinase Lyn are tested
next in the soluble fractions of the HLB and
HyperLB lysates. It has previously been shown that
Lyn is activated in response to MSU crystals (Gau-
Fig. 4. Fraction characterization. Neutrophils (4� 107 cells/ml) are
lysed in 2�SB or in HLB buffer. The insoluble materials of the
HLB lysis are further processed in HyperLB buffer as described in
the detailed procedure. Aliquots of each fraction are diluted in
2� SB and analysed by Western blot with specific antibodies or
Cholera toxin HRP-coupled.
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201 195
dry et al., 1995; Gilbert et al., 2002) and the
involvement of Lyn in activation via FcgRII has
also been described (Marcilla et al., 1995; Ibarrola et
al., 1997). To confirm this result following the
sequential lysis described here, neutrophils are stimu-
lated by pre-incubation with IV.3 F(abV)2 fragments
followed by addition of GAM for 1 min before being
lysed in HLB. HLB-soluble and -insoluble fractions
are prepared as described above. As the HLB-insolu-
ble material is also insoluble in ILB, the HLB-
insoluble fractions are directly resuspended in
HyperLB. Soluble and insoluble fractions are pre-
pared and Lyn is immunoprecipitated from the HLB-
and HyperLB-soluble fractions. The results shown in
Fig. 3B demonstrate that Lyn immunoprecipitated
from the HyperLB-soluble fractions retains in vitro
kinase activity. Furthermore, a stimulatory effect of
CD32 ligation on the auto-kinase activity of Lyn is
only detectable in the HyperLB lysates (Fig. 3B,
right side). Reblots indicate that equal amounts of
Lyn are immunoprecipitated and loaded in the con-
trol and CD32-stimulated cells (data not shown).
6.5. Characterization of the fractions
A partial characterization of the fractions obtained
during the sequential lysis protocol followed herein is
then carried out. Cytosolic markers (myeloid-related
protein-14 (MRP-14) and lactate dehydrogenase
(LDH)) are found predominantly in the soluble frac-
tion of the first lysis with HLB and in the soluble
fractions of the ultracentrifugation steps. Of relevance,
the receptor for cholera toxin (GM1) (Hart, 1975), a
major constituent of lipid rafts, is totally insoluble in
HLB buffer but is solubilized in HyperLB (Fig. 4).
Early endosome-associated protein-1 (EEA-1), an
endosomal marker, is equally distributed between
the soluble and insoluble fractions of HLB. The
HyperLB step completely solubilized EEA-1. Lyso-
some-associated membrane protein-1 (LAMP-1) is
entirely recovered in the HLB soluble fraction. Cytos-
keletal markers are also analyzed. A significant trans-
location of actin to the insoluble fraction is evident
after CD32 cross-linking as monitored by Coomassie
blue staining (Fig. 2). Paxillin and ezrin are equally
distributed between the soluble and the insoluble
fractions of the hypotonic lysis (Fig. 4). Extraction
with the hypertonic lysis buffer solubilized these
proteins. Finally, nuclear markers (p62 nucleoporin)
remain insoluble and are found in the pellets of the
HyperLB step (Fig. 4).
6.6. Association of kinase activity and Syk with CD32
precipitated in the HyperLB fractions
Stimulation of CD32 by cross-linking led to its
partitioning in the insoluble fraction in non-ionic
detergents, and, subsequently, its degradation (the
latter being reduced in the presence of tyrosine kinase
inhibitors (Barabe et al., 2002)). To confirm the
association of tyrosine kinase with CD32, CD32 is
cross-linked for increasing periods of time, the cell
pellets are lysed in HLB buffer and the insoluble
fractions are submitted to a second lysis in the
HyperLB as described above. The soluble material
of HyperLB fraction is incubated with 3 Ag of rabbit
anti mouse heavy/light chain antibodies and processed
for immunoprecipitation of CD32. Control experi-
ments established that the anti-CD32 antibodies fixed
on the cell by stimulation before lysis are preserved in
the presence of high salt concentrations and following
the sonication step. The immunoprecipitates are incu-
bated in a kinase buffer containing ATP and GST–
SAM68 fusion protein (as an exogenous substrate) for
10 min at 37 jC. The GST-fusion protein are recov-
ered with sepharose–GST beads and the CD32 immu-
noprecipitates are denaturated in 2� SB before
analysis by immunoblots (details in Section 4).
Immunoblots with an anti-phosphotyrosine anti-
body (Fig. 5, panel A) show a time-dependent asso-
ciation of tyrosine-phosphorylated proteins with the
CD32 immunoprecipitates. Two prominent bands
with migration characteristics that correspond to those
of CD32 and of the tyrosine Syk are consistently
detected. It should be pointed out that Src kinases are
masked by interference by the heavy chains of the
immunoprecipitating RAM antibodies. Association of
tyrosine kinase Syk with ITAM receptor has been
described upon CD32, CD64 and TCR activation
(Marcilla et al., 1995; Daeron, 1997; Bonnerot et
al., 1998). Immunomunoblot with anti-Syk antibodies
(panel B) reveal that the tyrosine kinase Syk is
present in the major tyrosine-phosphorylated band at
66 kDa observed in a panel A, and that this associ-
ation increased after CD32 ligation in a time-depend-
ent manner. Immunoblot with the anti-CD32 in panel
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201196
C shows that the amount of immunoprecipitated
CD32 is approximately equal. The results in panels
D and E confirm the presence of active tyrosine
kinase(s)-associated with CD32. Immunoblot of
GST–SAM68 precipitated with the anti-phosphotyr-
osine antibodies revealed that the CD32-associated
kinases are able to phosphorylate SAM68–GST
within 1 min of ligation, and that this phosphorylation
Fig. 6. Immunoprecipitation of tyrosine-phosphorylated proteins
from the HLB soluble and insoluble fractions. Neutrophils (4� 107
cells/ml) are stimulated by cross-linking CD32 as indicated in
Section 4. The reactions are stopped by a transfer of cell aliquots in
a precooled Eppendorf tube followed by rapid centrifugation. The
cell pellets are resuspended in HLB and the soluble and insoluble
fractions are diluted by 1/2 in boiling 2� LB. Immunoprecipita-
tions under denaturing conditions are performed as described in the
detailed procedure with the anti-Cbl, anti-Syk or anti-C32 anti-
bodies. Phosphorylated proteins are revealed with an anti-
phosphotyrosine antibody (upper panels), and the amount of
immunoprecipitated protein is visualized by immunoblot with the
respective antibodies (lower panels).
Fig. 5. Association of kinase Activity and Syk with the CD32
precipitated in the HyperLB fractions. Neutrophils (4� 107 cells/
ml) are stimulated by cross-linking CD32 for the indicated time at
37 jC as described in the detailed procedure. The reactions are
stopped by a transfer in a precooled Eppendorf tube followed by
rapid centrifugation. The cells are lysed with the HLB. The pellet of
the hypotonic lysis is directly incubated in a second lysis buffer
(HyperLB) and sonicated 2� 5 s. The soluble material (400 Al or16� 106 equivalent cells) of this lysis are diluted in 2 volumes of
HLB and incubated with 3 Ag of rabbit anti-mouse heavy/light chain
antibodies, and the immunoprecipitation and kinase activity assays
are performed as described in the detailed procedure. Kinase activity
associated with the CD32 is visualized by immunoblot with an anti-
phosphotyrosine antibodies (panel A). Protein associated with the
CD32 is identified in panel B by immunoblotting with an anti-Syk
antibodies. Amount of CD32 immunoprecipitated is evaluated in a
panel C with an anti-CD32 antibodies. Activity of associated
tyrosine kinases is verified in SAM68–GST precipitates as shown
in panels D and E by immunoblot with an anti-phosphotyrosine
antibodies (panel D) and anti-SAM68 (panel E).
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201 197
is maintained for least 10 min. Immunoblot with the
SAM68 antibodies revealed that equal amounts of
GST–SAM68 are precipitated and loaded onto each
lane.
6.7. Tyrosine-phosphorylated proteins are concen-
trated in the insoluble fractions
The results described above revealed a heteroge-
nous distribution of phosphorylated proteins among
the soluble and insoluble fractions derived from the
lysis protocols after CD32 engagement. We therefore
monitored more closely three major tyrosine-phos-
phorylated substrates previously identified following
CD32 cross-linking, namely, Cbl, Syk and CD32 itself
(Rollet-Labelle et al., 2000) (Fig. 6). Briefly, aliquots
of the soluble fractions derived from the lysis of
control and CD32-stimulated cells in HLB are resus-
pended in an equal volume of boiling 2�LB as
described in above. The insoluble material is resus-
pended in the same volume of HLB as the soluble
fractions and subsequently in an equal volume of
boiling 2�LB. Cbl, Syk and CD32 are immunopre-
cipitated from both fractions. The precipitates are
probed with antiphosphotyrosine antibodies as well
as with anti-Cbl, anti-Syk or anti-CD32 antibodies
(panels A, B and C, respectively). The results obtained
show that phosphorylated Cbl, Syk and CD32 are
highly concentrated in the insoluble fractions in agree-
ment with the observations of Figs. 3 and 5.
Reblots with anti-Cbl, anti-Syk or anti-CD32 anti-
bodies (lower panels) indicate that cross-linking of
CD32 did not grossly modulate the amounts of Cbl
and Syk present in each fraction. On the other hand, a
significant decrease in the level of CD32 is observed
in the soluble fractions, and this is compensated for, in
part at least, by an increase in the level of CD32 in the
insoluble fractions.
7. Discussion
The protocols described above provide a frame-
work for the immunobiochemical investigation of
tyrosine phosphorylation-dependent signaling path-
ways in human neutrophils. The basis of this method
is an initial lysis in a hypotonic buffer. Under these
conditions, the overall tyrosine phosphorylation pro-
file is preserved to a major extent. The two fractions
thus obtained (soluble and insoluble) can then be
further analyzed, either directly (in the case of the
soluble fractions) or following solubilization in buf-
fers of increasing tonicities (in the case of the original
insoluble fractions). Each fraction can be analyzed by
immunoblotting or by monitoring enzymatic activ-
ities.
A major characteristic of these protocols is that
they allow retention of the tyrosine phosphorylation
profile, maintain enzymatic activities and preserve
associations with surface receptors. This procedure
also established that the detergent solubility of indi-
vidual tyrosine-phosphorylated substrates differed,
not only according to the protein under investigation,
but also in response to the specific agonist used
(Gilbert et al., 2002).
The severe experimental problems associated with
the preparation of neutrophil lysates (proteolysis, de-
phosphorylation or hyperphosphorylation) are widely
acknowledged but poorly documented. A previous
attempt to preserve the original patterns of tyrosine
phosphorylation relied on a denaturing lysis protocol
which, while effective, eliminated the possibility of
studying protein–protein interactions and enzymatic
activities (i.e., kinases and phosphatases) in the lysates
(Al-Shami et al., 1997b). The sequential lysis protocol
described in the present manuscript overcomes these
limitations in that the lysates prepared under native
conditions maintained to a significant extent their
profile of tyrosine phosphorylation (Fig. 2) as well
as their enzymatic activities (Figs. 3–5) and protein–
protein associations with surface receptor (Fig. 5).
Furthermore, whereas the stimulation of tyrosine
phosphorylation is transient in intact neutrophils, we
observed that the tyrosine phosphorylation in the
insoluble fractions was maintained for up to 60 min
following cell lysis. This can be explained by the
technique used to stop the stimulation, i.e., transfer of
the cells in precooled tubes followed by rapid cen-
trifugation. This approach immediately eliminates the
incubation medium which may contain degradative
enzymes (proteases) and phosphatases released by the
cells during stimulation.
One of the main findings of the present investiga-
tion was that the detergent extractability of the tyro-
sine-phosphorylated substrates was both substrate- and
agonist-dependent (Gilbert et al., 2002). Nevertheless,
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201198
a large percentage of the tyrosine-phosphorylated
proteins was insoluble in regular RIPA buffers of
hypo- or iso-tonicity (Fig. 2). This point raises ques-
tions about the interpretation of immunoprecipitation
studies in which the fraction that is soluble in these
lysis buffers is used as starting material in the absence
of a detailed picture of the distribution of the protein
being examined. Furthermore, the level of phosphor-
ylation of various proteins can be artifactually
increased by the presence of Mg2 + in the lysis buffers
(Gilbert et al., 2002), a procedure sometimes adopted
to help preserve membrane and cytoskeletal integrity.
Once again, this may impact on the interpretation of
the functional significance of apparent stimulation, or
lack of stimulation, of the tyrosine phosphorylation of
specific substrates in those cases where the profiles of
tyrosine phosphorylation of the lysates used as starting
material for the immunoprecipitation differs signifi-
cantly from that of whole cells.
The importance of knowing the distribution of
proteins in detergent extracts of the cells is strikingly
illustrated by the behavior of CD32, Cbl and Syk in
response to stimulation by CD32 ligation. All three
proteins were rapidly tyrosine-phosphorylated follow-
ing CD32 cross-linking (Marcilla et al., 1995; Nacc-
ache et al., 1997; Rollet-Labelle et al., 2000) and, as
shown in Fig. 6, they were recovered in both the
soluble and the insoluble fractions. However, in all
three cases, the tyrosine-phosphorylated fractions of
these proteins were highly concentrated in the deter-
gent-insoluble fractions. The physiological relevance
of the soluble form of these proteins is therefore likely
to differ from that present in the insoluble fraction.
Cross-linking of CD32 induces its insolubility in non-
ionic detergents, thereby implicating a potential role
for detergent-resistant membranes (Barabe et al.,
2002; Gilbert et al., 2002). Insolubility of membrane
receptors coupled to kinase activities were also
observed in T cell lines (Solomon et al., 1998) and
in various others cells (Zhou et al., 1995). In the case
of the stimulation of CD32, we were able to detect not
only its insolubility (Barabe et al., 2002; Gilbert et al.,
2002) (Figs. 5 and 6) but also the appearance of
tyrosine kinase activity that rapidly (after 1 min of
ligation) associated with CD32 in the insoluble frac-
tion of the HLB. Association of Syk with ITAM
motifs after tyrosine phosphorylation by Src family
kinase is a central feature of the classical models for
ITAM-motif activation. The results obtained in Fig. 5
show that our procedures allowed a time-dependent
association of Syk with CD32 to be detected (panel
B). We also observed the tyrosine phosphorylation of
a prominent band with electrophoretic migration char-
acteristics of Syk when we incubated the precipitated
cross-linked CD32 in a kinase buffer (panel A).
Pretreatment of the cells with the Src inhibitor PP-2
abolished this association (data not shown) in accord-
ance with the classical model of ITAM activation
described by others (Marcilla et al., 1995; Daeron,
1997; Bonnerot et al., 1998).
The functional relevance of the above considera-
tions is also highlighted by the results of the experi-
ments in which the kinase activity of Lyn was
monitored in the soluble fractions of both the hypo-
tonic and hypertonic lysis buffers (Fig. 3). The
enzyme remained active in both fractions, an indica-
tion of preservation of structure and function in the
lysates. Of more functional relevance, however, was
the observation that the stimulatory effect of CD32
cross-linking on the activity of Lyn was only readily
detectable in the hypertonic buffer lysate. A study of
the soluble fraction of the hypotonic lysate would
have missed this effect, while a lysis in an isotonic
buffer would be likely to result in a significant level
of signal distortion (proteolysis, dephosphorylation).
The sequential lysis protocol characterized in the
present study overcomes several of these problems
by preserving the original phosphorylation status and
by sequentially giving access to the various fractions.
This observation indicates that both fractions must
always be examined in these kinds of studies. These
data are consistent with the results of Zhou et al.
(1995), who previously reported a partitioning of Src
kinase activities between in detergent insoluble frac-
tions derived from adherent neutrophils. These en-
zymes are involved in the early steps of several
neutrophil responses and are differentially regulated
depending of their intracellular distribution (Welch
and Maridonneau-Parini, 1997). Our results also indi-
cate that, depending on the agonist used, the distri-
bution of the tyrosine-phosphorylated substrates
varies and must be individually characterized. Fur-
thermore, the addition of cofactors in the lysis buffer
must be carefully controlled.
In conclusion, we have demonstrated that the
detergent-insoluble fractions cannot be excluded in
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201 199
biochemical studies of stimulated human neutrophils.
The concentration of signaling molecules in these
fractions may explain some of the controversial results
concerning tyrosine-phosphorylated proteins, tyrosine
kinase activities or protein associations that have been
reported in stimulated neutrophils. The present ap-
proach, which is based on the examination of all cell
fractions, may help to understand the biochemical
mechanisms regulating the functional responsiveness
of neutrophils. This method may also be extended to
the monitoring of phosphatase activities if Na3VO4 is
omitted from the lysis buffers allowing the evaluation
of the balance of kinase and phosphatase activities in
stimulated cells, which is most likely to be a key to the
regulation of several functional responses in many
cells.
8. Essential literature references
Al-Shami, A., Gilbert, C., Barabe, F., Gaudry, M.,
Naccache, P.H., 1997b. Preservation of the pattern of
tyrosine phosphorylation in human neutrophil lysates.
J. Immunol. Methods 202, 183–191.
Gilbert, C., Rollet-Labelle, E., Naccache, P.H.,
2002. Preservation of the pattern of tyrosine phos-
phorylation in human neutrophil lysates: II. A sequen-
tial lysis protocol for the analysis of tyrosine
phosphorylation-dependent signalling. J. Immunol.
Methods 261, 85–101.
Ignatoski, K.M., Verderame, M.F., 1996. Lysis
buffer composition dramatically affects extraction of
phosphotyrosine-containing proteins. BioTechniques
20, 794–796.
Welch, H., Maridonneau-Parini, I., 1997. Lyn and
Fgr are activated in distinct membrane fractions of
human granulocytic cells. Oncogene 15, 2021–2029.
Yan, S.R., Fumagalli, L., Berton, G., 1996. Acti-
vation of SRC family kinases in human neutrophils.
Evidence that p58C-FGR and p53/56LYN redistrib-
uted to a Triton X-100-insoluble cytoskeletal frac-
tion, also enriched in the caveolar protein caveolin,
display an enhanced kinase activity. FEBS Lett. 380,
198–203.
Zhou, M.J., Lublin, D.M., Link, D.C., Brown,
E.J., 1995. Distinct tyrosine kinase activation and
Triton X-100 insolubility upon Fc gamma RII or Fc
gamma RIIIB ligation in human polymorphonuclear
leukocytes. Implications for immune complex acti-
vation of the respiratory burst. J. Biol. Chem. 270,
13553–13560.
Acknowledgements
Supported in part by grants from the Canadian
Institutes of Health Research. C. Gilbert is supported
by fellowships from the K.M Hunter Charitable
Foundation, the Canadian Institutes of Health Re-
search and the Fonds pour la Formation de Cher-
cheurs et l’Aide a la Recherche and the Fonds de la
Recherche en Sante du Quebec.
References
Al-Shami, A., Bourgoin, S.G., Naccache, P.H., 1997a. Granulo-
cyte–macrophage colony-stimulating factor-activated signaling
pathways in human neutrophils: I. Tyrosine phosphorylation-
dependent stimulation of phosphatidylinositol 3-kinase and in-
hibition by phorbol esters. Blood 89, 1035–1044.
Al-Shami, A., Gilbert, C., Barabe, F., Gaudry, M., Naccache, P.H.,
1997b. Preservation of the pattern of tyrosine phosphorylation in
human neutrophil lysates. J. Immunol. Methods 202, 183–191.
Barabe, F., Gilbert, C., Liao, N., Bourgoin, S.G., Naccache, P.H.,
1998. Crystal-induced neutrophil activation: VI. Involvement of
FcgammaRIIIB (CD16) and CD11b in response to inflammatory
microcrystals. FASEB J. 12, 209–220.
Barabe, F., Rollet-Labelle, E., Gilbert, C., Fernandes, M.J., Nacc-
ache, S.N., Naccache, P.H., 2002. Early events in the activation
of FcgammaRIIA in human neutrophils: stimulated insolubiliza-
tion, translocation to detergent-resistant domains, and degrada-
tion of FcgammaRIIA. J. Immunol. 168, 4042–4049.
Bonnerot, C., Briken, V., Brachet, V., Lankar, D., Cassard, S., Jabri,
B., Amigorena, S., 1998. Syk protein tyrosine kinase regulates
Fc receptor gamma-chain-mediated transport to lysosomes. EM-
BO J. 17, 4606–4616.
Brown, D.A., London, E., 1998. Functions of lipid rafts in bio-
logical membranes. Annu. Rev. Cell Dev. Biol. 14, 111–136.
Daeron, M., 1997. Fc receptor biology. Annu. Rev. Immunol. 15,
203–234.
Gaudry, M., Gilbert, C., Barabe, F., Poubelle, P.E., Naccache, P.H.,
1995. Activation of Lyn is a common element of the stimulation
of human neutrophils by soluble and particulate agonists. Blood
86, 3567–3574.
Gilbert, C., Barabe, F., Rollet-Labelle, E., Bourgoin, S.G., McColl,
S.R., Damaj, B.B., Naccache, P.H., 2001. Evidence for a role for
SAM68 in the responses of human neutrophils to ligation of
CD32 and to monosodium urate crystals. J. Immunol. 166,
4664–4671.
Gilbert, C., Rollet-Labelle, E., Naccache, P.H., 2002. Preservation
of the pattern of tyrosine phosphorylation in human neutrophil
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201200
lysates: II. A sequential lysis protocol for the analysis of tyro-
sine phosphorylation-dependent signalling. J. Immunol. Meth-
ods 261, 85–101.
Hart, D., 1975. Evidence for the non-protein nature of the receptor
for the enterotoxin in Vibrio cholerae on murine lymphoid cells.
Infect. Immun. 11, 742–747.
Ibarrola, I., Vossebeld, P.J., Homburg, C.H., Thelen, M., Roos, D.,
Verhoeven, A.J., 1997. Influence of tyrosine phosphorylation on
protein interaction with FcgammaRIIa. Biochim. Biophys. Acta
1357, 348–358.
Ignatoski, K.M., Verderame, M.F., 1996. Lysis buffer composition
dramatically affects extraction of phosphotyrosine-containing
proteins. BioTechniques 20, 794–796.
Khamzina, L., Borgeat, P., 1998. Correlation of alpha-fetoprotein
expression in normal hepatocytes during development with ty-
rosine phosphorylation and insulin receptor expression. Mol.
Biol. Cell 9, 1093–1105.
Marcilla, A., Rivero-Lezcano, O.M., Agarwal, A., Robbins, K.C.,
1995. Identification of the major tyrosine kinase substrate in
signaling complexes formed after engagement of Fc gamma
receptors. J. Biol. Chem. 270, 9115–9120.
McDonald, P.P., Bovolenta, C., Cassatella, M., 1998. Activation
of distinct transcription factors in neutrophils by bacterial
LPS, interferon gamma and GM-CSF and necessity to over-
come the action of endogenous proteases. Biochemistry 37,
13173–13265.
Naccache, P.H., Gilbert, C., Barabe, F., Al-Shami, A., Mahana, W.,
Bourgoin, S.G., 1997. Agonist-specific tyrosine phosphoryla-
tion of Cbl in human neutrophils. J. Leukoc. Biol. 62, 901–910.
Papavassiliou, A.G., 1994. Preservation of protein phosphoryl
groups in immunoprecipitation assays. J. Immunol. Methods
170, 67–73.
Pouliot, M., McDonald, P.P., Krump, E., Mancini, J.A., McColl,
S.R., Weech, P.K., Borgeat, P., 1996. Colocalization of cytosolic
phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase-activat-
ing protein at the nuclear membrane of A23187-stimulated hu-
man neutrophils. Eur. J. Biochem. 238, 250–258.
Pouliot, M., Gilbert, C., Borgeat, P., Poubelle, P.E., Bourgoin, S.,
Creminon, C., Maclouf, J., McColl, S.R., Naccache, P.H., 1998.
Expression and activity of prostanglandin endoperoxide syn-
thase-2 in agonist-activated human neutrophils. FASEB J. 12,
1109–1123.
Rollet, E., Caon, A.C., Roberge, C.J., Liao, N.W., Malawista, S.E.,
McColl, S.R., Naccache, P.H., 1994. Tyrosine phosphorylation
in activated human neutrophils. Comparison of the effects of
different classes of agonists and identification of the signaling
pathways involved. J. Immunol. 153, 353–363.
Rollet-Labelle, E., Gilbert, C., Naccache, P.H., 2000. Modulation of
human neutrophil responses to CD32 cross-linking by serine/
threonine phosphatase inhibitors: cross-talk between serine/
threonine and tyrosine phosphorylation. J. Immunol. 164,
1020–1028.
Simons, K.T.D., 2000. Lipid rafts and signal transduction. Nat. Rev.
1, 31–39.
Smith, J.A., 1994. Neutrophils, host defense, and inflammation: a
double-edged sword. J. Leukoc. Biol. 56, 672.
Solomon, K.R., Mallory, M.A., Finberg, R.W., 1998. Determination
of the non-ionic detergent insolubility and phosphoprotein asso-
ciations of glycosylphosphatidylinositol-anchored proteins ex-
pressed on T cells. Biochem. J. 334, 325–333.
Welch, H., Maridonneau-Parini, I., 1997. Lyn and Fgr are activated
in distinct membrane fractions of human granulocytic cells. On-
cogene 15, 2021–2029.
Yan, S.R., Fumagalli, L., Berton, G., 1996. Activation of SRC
family kinases in human neutrophils. Evidence that p58C-
FGR and p53/56LYN redistributed to a Triton X-100-insoluble
cytoskeletal fraction, also enriched in the caveolar protein cav-
eolin, display an enhanced kinase activity. FEBS Lett. 380,
198–203.
Zhou, M.J., Lublin, D.M., Link, D.C., Brown, E.J., 1995. Distinct
tyrosine kinase activation and Triton X-100 insolubility upon Fc
gamma RII or Fc gamma RIIIB ligation in human polymorpho-
nuclear leukocytes. Implications for immune complex activation
of the respiratory burst. J. Biol. Chem. 270, 13553–13560.
C. Gilbert et al. / Journal of Immunological Methods 271 (2002) 185–201 201